LEO 90100 in the Treatment of Psoriasis Vulgaris

NCT01536938 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

303

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis Vulgaris

Interventions

DRUG: LEO 90100
DRUG: Calcipotriol
DRUG: Betamethasone

Sponsor

LEO Pharma